Cancer Research PRL Inhibitor Induces the Cleavage of p130Cas Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 56, 4103-4107, September 15, 1996]
© 1996 American Association for Cancer Research
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wei, Q.
Right arrow Articles by Spitz, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wei, Q.
Right arrow Articles by Spitz, M. R.

Reduced DNA Repair Capacity in Lung Cancer Patients1

Qingyi Wei2, Lie Cheng, Waun Ki Hong and Margaret R. Spitz

Departments of Epidemiology [Q. W., L. C., M. R. S.] and Thoracic and Head and Neck Medical Oncology [W. K. H.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Although lung cancer is the paradigm of a tobacco-induced malignancy, host-specific factors modulate susceptibility to tobacco carcinogenesis. Variations in DNA repair may influence the rate of removal of DNA damage and of fixation of mutations. To test the hypothesis that genetically determined DNA repair capacity (DRC) modulates lung cancer susceptibility, we conducted a pilot case-control study of 51 patients with newly diagnosed, previously untreated lung cancer and 56 controls identified from local community centers and frequency matched to the cases on age, sex, and ethnicity. The subjects were ascertained and interviewed for an ongoing molecular epidemiological investigation of lung cancer susceptibility. We measured DRC in the subjects' peripheral blood lymphocytes by using the host-cell reactivation assay, which measures cellular reactivation of a reporter gene damaged by exposure to 75 µM benzo(a)pyrene diol epoxide. The mean level of DRC in cases (3.3%) was significantly lower than that in controls (5.1%) (P < 0.01). Only nine cases (18%) had DNA repair levels greater than the median value of repair in the controls. This median level of DRC in controls was used as the cutoff value for calculating the odds ratios. After adjustment for age, sex, ethnicity, and smoking status, the cases were five times more likely than the controls to have reduced DRC (odds ratio, 5.7; 95% confidence interval, 2.1–15.7). Younger cases (<65 years) and smokers were more likely than controls to have reduced DRC. These findings suggest that individuals with reduced DRC are at an increased risk of developing lung cancer.

1 This research was supported by an institutional start-up grant (to Q. W.) and NIH Grants CA 55769 (to M. R. S.) and U19 CA 68437 (to W. K. H.).

2 To whom requests for reprints should be addressed, at Department of Epidemiology, Box 189, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: (713) 792-3020; Fax: (713) 792-0807; E-mail: qwei@request.mda.uth.tmc.edu.

Received 6/14/96. Accepted 7/30/96.




This article has been cited by other articles:


Home page
 Anticancer ResHome page
B. AGACHAN, O. KUCUKHUSEYIN, P. AKSOY, A. TURNA, I. YAYLIM, U. GORMUS, A. ERGEN, U. ZEYBEK, B. DALAN, and T. ISBIR
Apurinic/Apyrimidinic Endonuclease (APE1) Gene Polymorphisms and Lung Cancer Risk in Relation To Tobacco Smoking
Anticancer Res, June 1, 2009; 29(6): 2417 - 2420.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Saviozzi, P. Ceppi, S. Novello, P. Ghio, M. Lo Iacono, P. Borasio, A. Cambieri, M. Volante, M. Papotti, R. A. Calogero, et al.
Non-Small Cell Lung Cancer Exhibits Transcript Overexpression of Genes Associated with Homologous Recombination and DNA Replication Pathways
Cancer Res., April 15, 2009; 69(8): 3390 - 3396.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
E.L. Crawford, T. Blomquist, D.N. Mullins, Y. Yoon, D.R. Hernandez, M. Al-Bagdhadi, J. Ruiz, J. Hammersley, and J.C. Willey
CEBPG regulates ERCC5/XPG expression in human bronchial epithelial cells and this regulation is modified by E2F1/YY1 interactions
Carcinogenesis, December 1, 2007; 28(12): 2552 - 2559.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
L. Wang, Q. Wei, Q. Shi, Z. Guo, Y. Qiao, and M. R. Spitz
A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma
Carcinogenesis, July 1, 2007; 28(7): 1430 - 1436.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Monzo, S. Brunet, A. Urbano-Ispizua, A. Navarro, G. Perea, J. Esteve, R. Artells, M. Granell, J. Berlanga, J. M. Ribera, et al.
Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia
Blood, June 15, 2006; 107(12): 4871 - 4879.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
R. de las Penas, M. Sanchez-Ronco, V. Alberola, M. Taron, C. Camps, R. Garcia-Carbonero, B. Massuti, C. Queralt, M. Botia, R. Garcia-Gomez, et al.
Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients
Ann. Onc., April 1, 2006; 17(4): 668 - 675.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Blankenburg, I. R. Konig, R. Moessner, P. Laspe, K.-M. Thoms, U. Krueger, S. G. Khan, G. Westphal, C. Berking, M. Volkenandt, et al.
Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study
Carcinogenesis, June 1, 2005; 26(6): 1085 - 1090.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Suk, S. Gurubhagavatula, S. Park, W. Zhou, L. Su, T. J. Lynch, J. C. Wain, D. Neuberg, G. Liu, and D. C. Christiani
Polymorphisms in ERCC1 and Grade 3 or 4 Toxicity in Non-Small Cell Lung Cancer Patients
Clin. Cancer Res., February 15, 2005; 11(4): 1534 - 1538.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
W. Zhou, G. Liu, S. Park, Z. Wang, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani
Gene-Smoking Interaction Associations for the ERCC1 Polymorphisms in the Risk of Lung Cancer
Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 491 - 496.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
O. Popanda, T. Schattenberg, C. T. Phong, D. Butkiewicz, A. Risch, L. Edler, K. Kayser, H. Dienemann, V. Schulz, P. Drings, et al.
Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer
Carcinogenesis, December 1, 2004; 25(12): 2433 - 2441.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. S. Marin, M. F. Lopez-Cima, L. Garcia-Castro, T. Pascual, M. G. Marron, and A. Tardon
Poly (AT) Polymorphism in Intron 11 of the XPC DNA Repair Gene Enhances the Risk of Lung Cancer
Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1788 - 1793.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Q. Lan, J. L. Mumford, M. Shen, D. M. DeMarini, M. R. Bonner, X. He, M. Yeager, R. Welch, S. Chanock, L. Tian, et al.
Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions
Carcinogenesis, November 1, 2004; 25(11): 2177 - 2181.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Q. Shi, L.-E. Wang, M. L. Bondy, A. Brewster, S. E. Singletary, and Q. Wei
Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients
Carcinogenesis, September 1, 2004; 25(9): 1695 - 1700.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. Koeppel, V. Poindessous, V. Lazar, E. Raymond, A. Sarasin, and A. K. Larsen
Irofulven Cytotoxicity Depends on Transcription-Coupled Nucleotide Excision Repair and Is Correlated with XPG Expression in Solid Tumor Cells
Clin. Cancer Res., August 15, 2004; 10(16): 5604 - 5613.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
D. Isla, C. Sarries, R. Rosell, G. Alonso, M. Domine, M. Taron, G. Lopez-Vivanco, C. Camps, M. Botia, L. Nunez, et al.
Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer
Ann. Onc., August 1, 2004; 15(8): 1194 - 1203.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
H. Ito, K. Matsuo, N. Hamajima, T. Mitsudomi, T. Sugiura, T. Saito, T. Yasue, K.-M. Lee, D. Kang, K.-Y. Yoo, et al.
Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk
Carcinogenesis, August 1, 2004; 25(8): 1395 - 1401.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Gurubhagavatula, G. Liu, S. Park, W. Zhou, L. Su, J. C. Wain, T. J. Lynch, D. S. Neuberg, and D. C. Christiani
XPD and XRCC1 Genetic Polymorphisms Are Prognostic Factors in Advanced Non--Small-Cell Lung Cancer Patients Treated With Platinum Chemotherapy
J. Clin. Oncol., July 1, 2004; 22(13): 2594 - 2601.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
W.-M. Gao, M. Romkes, R. D. Day, J. M. Siegfried, J. D. Luketich, H. H. Mady, M. F. Melhem, and P. Keohavong
Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer
Carcinogenesis, October 1, 2003; 24(10): 1671 - 1676.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
H.-S. Jeon, K. M. Kim, S. H. Park, S. Y. Lee, J. E. Choi, G. Y. Lee, S. Kam, R. W. Park, I.-S. Kim, C. H. Kim, et al.
Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer
Carcinogenesis, October 1, 2003; 24(10): 1677 - 1681.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. E. Choi, S. H. Park, H.-S. Jeon, K. M. Kim, G. Y. Lee, R. W. Park, S. Kam, I.-S. Kim, C. H. Kim, S. H. Jheon, et al.
No Association between Haplotypes of Three Variants (Codon 81, 284, and 762) in Poly(ADP-ribose) Polymerase Gene and Risk of Primary Lung Cancer
Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 947 - 949.
[Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. R. Spitz, Q. Wei, Q. Dong, C. I. Amos, and X. Wu
Genetic Susceptibility to Lung Cancer: The Role of DNA Damage and Repair
Cancer Epidemiol. Biomarkers Prev., August 1, 2003; 12(8): 689 - 698.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Speina, M. Zielinska, A. Barbin, D. Gackowski, J. Kowalewski, M. A. Graziewicz, J. A. Siedlecki, R. Olinski, and B. Tudek
Decreased Repair Activities of 1,N6-Ethenoadenine and 3,N4-Ethenocytosine in Lung Adenocarcinoma Patients
Cancer Res., August 1, 2003; 63(15): 4351 - 4357.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
W. Zhou, G. Liu, D. P. Miller, S. W. Thurston, L. L. Xu, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani
Polymorphisms in the DNA Repair Genes XRCC1 and ERCC2, Smoking, and Lung Cancer Risk
Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 359 - 365.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. Y. Park, S. H. Park, J. E. Choi, S. Y. Lee, H.-S. Jeon, S. I. Cha, C. H. Kim, J.-H. Park, S. Kam, R. W. Park, et al.
Polymorphisms of the DNA Repair Gene Xeroderma Pigmentosum Group A and Risk of Primary Lung Cancer
Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 993 - 997.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
U. Vogel, P. Moller, L. Dragsted, S. Loft, A. Pedersen, and B. Sandstrom
Inter-individual variation, seasonal variation and close correlation of OGG1 and ERCC1 mRNA levels in full blood from healthy volunteers
Carcinogenesis, September 1, 2002; 23(9): 1505 - 1509.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Chen, D. Tang, K. Xue, L. Xu, G. Ma, Y. Hsu, and S. S. Cho
DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population
Carcinogenesis, August 1, 2002; 23(8): 1321 - 1325.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
C. H. Bosken, Q. Wei, C. I. Amos, and M. R. Spitz
An Analysis of DNA Repair as a Determinant of Survival in Patients With Non-Small-Cell Lung Cancer
J Natl Cancer Inst, July 17, 2002; 94(14): 1091 - 1099.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. Zhou, G. Liu, D. P. Miller, S. W. Thurston, L. L. Xu, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani
Gene-Environment Interaction for the ERCC2 Polymorphisms and Cumulative Cigarette Smoking Exposure in Lung Cancer
Cancer Res., March 1, 2002; 62(5): 1377 - 1381.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. T. Landi, A. Baccarelli, R. E. Tarone, A. Pesatori, M. A. Tucker, M. Hedayati, and L. Grossman
DNA Repair, Dysplastic Nevi, and Sunlight Sensitivity in the Development of Cutaneous Malignant Melanoma
J Natl Cancer Inst, January 16, 2002; 94(2): 94 - 101.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. Y. Park, S. Y. Lee, H.-S. Jeon, N. C. Bae, S. C. Chae, S. Joo, C. H. Kim, J.-H. Park, S. Kam, I. S. Kim, et al.
Polymorphism of the DNA Repair Gene XRCC1 and Risk of Primary Lung Cancer
Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 23 - 27.
[Abstract] [Full Text]

Home page
 JCOHome page
S. M. Lippman and M. R. Spitz
Lung Cancer Chemoprevention: An Integrated Approach
J. Clin. Oncol., September 15, 2001; 19(90001): 74s - 82.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
G. L. David-Beabes, R. M. Lunn, and S. J. London
No Association between the XPD (Lys751G1n) Polymorphism or the XRCC3 (Thr241Met) Polymorphism and Lung Cancer Risk
Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 911 - 912.
[Full Text] [PDF]

Home page
 CarcinogenesisHome page
U. Vogel, M. Hedayati, M. Dybdahl, L. Grossman, and B. A. Nexo
Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited
Carcinogenesis, June 1, 2001; 22(6): 899 - 904.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D.T. Bau, J.R. Gurr, and K.Y. Jan
Nitric oxide is involved in arsenite inhibition of pyrimidine dimer excision
Carcinogenesis, May 1, 2001; 22(5): 709 - 716.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D. H. Auckley, R. E. Crowell, E. R. Heaphy, C. A. Stidley, J. F. Lechner, F. D. Gilliland, and S. A. Belinsky
Reduced DNA-dependent protein kinase activity is associated with lung cancer
Carcinogenesis, May 1, 2001; 22(5): 723 - 727.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
S. Emmert, T. D. Schneider, S. G. Khan, and K. H. Kraemer
The human XPG gene: gene architecture, alternative splicing and single nucleotide polymorphisms
Nucleic Acids Res., April 1, 2001; 29(7): 1443 - 1452.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D. Butkiewicz, M. Rusin, L. Enewold, P. G. Shields, M. Chorazy, and C. C. Harris
Genetic polymorphisms in DNA repair genes and risk of lung cancer
Carcinogenesis, April 1, 2001; 22(4): 593 - 597.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Shen, E. M. Sturgis, S. G. Khan, Y. Qiao, T. Shahlavi, S. A. Eicher, Y. Xu, X. Wang, S. S. Strom, M. R. Spitz, et al.
An Intronic Poly (AT) Polymorphism of the DNA Repair Gene XPC and Risk of Squamous Cell Carcinoma of the Head and Neck: A Case-Control Study
Cancer Res., April 1, 2001; 61(8): 3321 - 3325.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
D. Tomescu, G. Kavanagh, T. Ha, H. Campbell, and D. W. Melton
Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma
Carcinogenesis, March 1, 2001; 22(3): 403 - 408.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
D. Ratnasinghe, S.-X. Yao, J. A. Tangrea, Y.-L. Qiao, M. R. Andersen, M. J. Barrett, C. A. Giffen, Y. Erozan, M. S. Tockman, and P. R. Taylor
Polymorphisms of the DNA Repair Gene XRCC1 and Lung Cancer Risk
Cancer Epidemiol. Biomarkers Prev., February 1, 2001; 10(2): 119 - 123.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
M. R. Spitz, X. Wu, Y. Wang, L.-E Wang, S. Shete, C. I. Amos, Z. Guo, L. Lei, H. Mohrenweiser, and Q. Wei
Modulation of Nucleotide Excision Repair Capacity by XPD Polymorphisms in Lung Cancer Patients
Cancer Res., February 1, 2001; 61(4): 1354 - 1357.
[Abstract] [Full Text]

Home page
 MutagenesisHome page
P. Schmezer, N. Rajaee-Behbahani, A. Risch, S. Thiel, W. Rittgen, P. Drings, H. Dienemann, K. W. Kayser, V. Schulz, and H. Bartsch
Rapid screening assay for mutagen sensitivity and DNA repair capacity in human peripheral blood lymphocytes
Mutagenesis, January 1, 2001; 16(1): 25 - 30.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
Qingyi Wei, Lie Cheng, C. I. Amos, L.-E. Wang, Zhaozheng Guo, W. K. Hong, and M. R. Spitz
Repair of Tobacco Carcinogen-Induced DNA Adducts and Lung Cancer Risk: a Molecular Epidemiologic Study
J Natl Cancer Inst, November 1, 2000; 92(21): 1764 - 1772.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
M. Z. Hadi, M. A. Coleman, K. Fidelis, H. W. Mohrenweiser, and D. M. Wilson III
Functional characterization of Ape1 variants identified in the human population
Nucleic Acids Res., October 15, 2000; 28(20): 3871 - 3879.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. L. Winsey, N. A. Haldar, H. P. Marsh, M. Bunce, S. E. Marshall, A. L. Harris, F. Wojnarowska, and K. I. Welsh
A Variant within the DNA Repair Gene XRCC3 Is Associated with the Development of Melanoma Skin Cancer
Cancer Res., October 1, 2000; 60(20): 5612 - 5616.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
L. Cheng, M. R. Spitz, W. K. Hong, and Q. Wei
Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis
Carcinogenesis, August 1, 2000; 21(8): 1527 - 1530.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. Berwick and P. Vineis
Markers of DNA Repair and Susceptibility to Cancer in Humans: an Epidemiologic Review
J Natl Cancer Inst, June 7, 2000; 92(11): 874 - 897.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. B. Schabath, M. R. Spitz, X. Zhang, G. L. Delclos, and X. Wu
Genetic variants of myeloperoxidase and lung cancer risk
Carcinogenesis, June 1, 2000; 21(6): 1163 - 1166.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
F. P. Perera
Molecular Epidemiology: On the Path to Prevention?
J Natl Cancer Inst, April 19, 2000; 92(8): 602 - 612.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
W. N. ROM, J. G. HAY, T. C. LEE, Y. JIANG, and K.-M. TCHOU-WONG
Molecular and Genetic Aspects of Lung Cancer
Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1355 - 1367.
[Full Text]

Home page
 JNCI J Natl Cancer InstHome page
Q. Wei, M. L. Frazier, and B. Levin
DNA Repair: a Double-Edged Sword
J Natl Cancer Inst, March 15, 2000; 92(6): 440 - 441.
[Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
L. Cheng, Y. Guan, L. Li, R. J. Legerski, J. Einspahr, J. Bangert, D. S. Alberts, and Q. Wei
Expression in Normal Human Tissues of Five Nucleotide Excision Repair Genes Measured Simultaneously by Multiplex Reverse Transcription-Polymerase Chain Reaction
Cancer Epidemiol. Biomarkers Prev., September 1, 1999; 8(9): 801 - 807.
[Abstract] [Full Text]

Home page
 ThoraxHome page
D. W Kamp and S. A Weitzman
The molecular basis of asbestos induced lung injury
Thorax, July 1, 1999; 54(7): 638 - 652.
[Full Text]

Home page
 Clin. Cancer Res.Home page
R. Rosell, R. Calvo, J. J. Sanchez, J. Maurel, M. Guillot, M. Monzo, L. Nunez, and A. Barnadas
Genetic Susceptibility Associated with Rare HRAS1 Variable Number of Tandem Repeats Alleles in Spanish Non-Small Cell Lung Cancer Patients
Clin. Cancer Res., July 1, 1999; 5(7): 1849 - 1854.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. D’Errico, A. Calcagnile, I. Iavarone, F. Sera, G. Baliva, L. M. Chinni, R. Corona, P. Pasquini, and E. Dogliotti
Factors That Influence the DNA Repair Capacity of Normal and Skin Cancer-affected Individuals
Cancer Epidemiol. Biomarkers Prev., June 1, 1999; 8(6): 553 - 559.
[Abstract] [Full Text]

Home page
 Arch Otolaryngol Head Neck SurgHome page
E. M. Sturgis, G. L. Clayman, Y. Guan, Z. Guo, and Q. Wei
DNA Repair in Lymphoblastoid Cell Lines From Patients With Head and Neck Cancer
Arch Otolaryngol Head Neck Surg, February 1, 1999; 125(2): 185 - 190.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. Dybdahl, U. Vogel, G. Frentz, H. Wallin, and B. A. Nexø
Polymorphisms in the DNA Repair Gene XPD: Correlations with Risk and Age at Onset of Basal Cell Carcinoma
Cancer Epidemiol. Biomarkers Prev., January 1, 1999; 8(1): 77 - 81.
[Abstract] [Full Text]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
G. Romano, A. Sgambato, A. Boninsegna, G. Flamini, G. Curigliano, Q. Yang, V. La Gioia, C. Signorelli, A. Ferro, G. Capelli, et al.
Evaluation of Polycyclic Aromatic Hydrocarbon-DNA Adducts in Exfoliated Oral Cells by an Immunohistochemical Assay
Cancer Epidemiol. Biomarkers Prev., January 1, 1999; 8(1): 91 - 96.
[Abstract] [Full Text]

Home page
 ScienceHome page
F. P. Perera
Environment and Cancer: Who Are Susceptible?
Science, November 7, 1997; 278(5340): 1068 - 1073.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.